MetaADEDB 2.0 @ LMMD
Gabexate
(DNTNDFLIKUKKOC-UHFFFAOYSA-N)
Structure
SMILES
CS(=O)(=O)O.CCOC(=O)c1ccc(cc1)OC(=O)CCCCCN=C(N)N
Molecular Formula:
C17H27N3O7S
Molecular Weight:
417.477
Log P:
3.5879
Hydrogen Bond Acceptor:
10
Hydrogen Bond Donor:
3
TPSA:
179.75
CAS Number(s):
39492-01-8; 56974-61-9
Synonym(s)
1.
Gabexate
2.
Foy
3.
Gabexate Mesilate
4.
Gabexate Mesylate
5.
Gabexate Methanesulfonate
6.
Gabexate Monomethanesulfonate
7.
Gabexate Monomethanesulfonate, 14C-Labeled Cpd
8.
Gabexate Monomethanesulfonate, 14C Labeled Cpd
9.
Mesilate, Gabexate
10.
Mesylate, Gabexate
11.
Methanesulfonate, Gabexate
12.
Monomethanesulfonate, Gabexate
External Link(s)
MeSHD016670
PubChem Compound74438478
6604561
ChEBI31641
CHEMBLCHEMBL1398351
KEGGdr:D01672
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AcidosisOFFSIDES
2Alanine Aminotransferase IncreasedOFFSIDES
3Albumin globulin ratio decreasedOFFSIDES
4Altered state of consciousnessOFFSIDES
5AnisocoriaOFFSIDES
6AnuriaOFFSIDES
7Artificial anusOFFSIDES
8Aspartate aminotransferase decreasedOFFSIDES
9AutomatismOFFSIDES
10Band neutrophil percentage increasedOFFSIDES
11Basophil percentage increasedOFFSIDES
12BasophiliaOFFSIDES
13Blood GlucoseOFFSIDES
14Blood albumin decreasedOFFSIDES
15Blood alkaline phosphatase increasedOFFSIDES
16Blood amylase increasedOFFSIDES
17Blood creatine phosphokinase decreasedOFFSIDES
18Blood creatine phosphokinase increasedOFFSIDES
19Blood creatinine decreasedOFFSIDES
20Blood creatinine increasedOFFSIDES
21Blood lactate dehydrogenase increasedOFFSIDES
22Blood magnesium decreasedOFFSIDES
23Blood potassium increasedOFFSIDES
24Blood sodiumOFFSIDES
25BradycardiaOFFSIDES
26Cerebral hypoperfusionOFFSIDES
27CheilitisOFFSIDES
28CystOFFSIDES
29Cytomegalovirus test positiveOFFSIDES
30Depressed Level of ConsciousnessOFFSIDES
31DiabetesOFFSIDES
32DiarrheaOFFSIDES
33Disease ProgressionOFFSIDES
34Disease recurrenceOFFSIDES
35Disseminated Intravascular CoagulationOFFSIDES
36ErythemaOFFSIDES
37Gamma-Glutamyltransferase IncreasedOFFSIDES
38Gaze palsyOFFSIDES
39GlossoptosisOFFSIDES
40HemothoraxOFFSIDES
41Hepatic artery stenosisOFFSIDES
42Hepatic necrosisOFFSIDES
43Hepatic vein occlusionOFFSIDES
44Hepatic vein stenosisOFFSIDES
45Hepatobiliary infectionOFFSIDES
46Histiocytosis haematophagicOFFSIDES
47HypercapniaOFFSIDES
48IncontinenceOFFSIDES
49Infusion Site ExtravasationOFFSIDES
50Kidney FailureOFFSIDES
51LeukoencephalopathyOFFSIDES
52Leukopenia neonatalOFFSIDES
53Mental status changesOFFSIDES
54Metabolic acidosisOFFSIDES
55Metastases to abdominal cavityOFFSIDES
56Neutrophil count decreasedOFFSIDES
57OliguriaOFFSIDES
58PallorOFFSIDES
59Pancreatic PseudocystOFFSIDES
60PancreatitisOFFSIDES
61PeritonitisOFFSIDES
62Portal Vein ThrombosisOFFSIDES
63Post procedural complicationOFFSIDES
64Pyoderma GangrenosumOFFSIDES
65Renal tubular disorderOFFSIDES
66Renal tubular necrosisOFFSIDES
67Respiratory FailureOFFSIDES
68Retinal Vein OcclusionOFFSIDES
69Retro-peritoneal space operationOFFSIDES
70Retroperitoneal lymphadenopathyOFFSIDES
71ScotomaOFFSIDES
72StridorOFFSIDES
73Suture ruptureOFFSIDES
74Transaminases increasedOFFSIDES
75Viral DNA test positiveOFFSIDES
76Visual disturbanceOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.